Showing results (271-280 of 657) with videos related to
Sort By:
Pageof 66
Plos One|March 13, 2014
Testosterone induces molecular changes in dopamine signaling pathway molecules in the adolescent male rat nigrostriatal pathwayTertia D Purves-Tyson, Samantha J Owens, Kay L Double, et al.Molecular and Cellular Endocrinology|June 14, 2011
Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivoUlla Simanainen, Michele Brogley, Yan Ru Gao, et al.Endocrine-Related Cancer|August 20, 2015
Androgen actions via androgen receptor promote PTEN inactivation induced uterine cancerJaesung Peter Choi, Reena Desai, Yu Zheng, et al.Endocrine Connections|June 17, 2021
Optimal injection interval for testosterone undecanoate treatment of hypogonadal and transgender menNandini Shankara Narayana, Lam P Ly, Veena Jayadev, et al.Annals of Clinical Biochemistry|March 18, 2015
Requirement for specific gravity and creatinine adjustments for urinary steroids and luteinizing hormone concentrations in adolescentsGurmeet K S Singh, Ben W R Balzer, Reena Desai, et al.Clinical Nutrition (Edinburgh, Scotland)|July 23, 2023
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitionsDavid Scott, Fiona Blyth, Vasi Naganathan, et al.Hormones & Cancer|August 11, 2016
Global or Granulosa Cell-Specific Pten Mutations in Combination with Elevated FSH Levels Fail to Cause Ovarian Tumours in MiceDannielle H Upton, Kirsty A Walters, Rachel E Allavena, et al.International Journal of Biological Sciences|December 27, 2018
Androgen action augments ischemia-induced, bone marrow progenitor cell-mediated vasculogenesisYuen Ting Lam, Laura Lecce, Gloria S C Yuen, et al.Proceedings of the National Academy of Sciences of the United States of America|December 15, 2010
Follicle-stimulating hormone increases bone mass in female miceCharles M Allan, Robert Kalak, Colin R Dunstan, et al.Annals of Internal Medicine|November 17, 2010
Long-term effects of dihydrotestosterone treatment on prostate growth in healthy, middle-aged men without prostate disease: a randomized, placebo-controlled trialAmanda Idan, Kaye A Griffiths, D Tim Harwood, et al.Pageof 66